
HURN Stock Forecast & Price Target
HURN Analyst Ratings
Bulls say
Huron Consulting Group Inc is projecting a revenue-based growth rate (RBR) in the range of $1.580 to $1.660 billion, signifying an increase of 6.3% to 11.7% year-over-year, which reflects strong overall company performance. The commercial segment, accounting for 19% of total revenue, demonstrated impressive growth of 17.0% year-over-year in Q1/25, indicating resilience amid industry disruptions. Additionally, the healthcare segment exhibited a solid organic growth rate of 12% year-over-year, highlighting the company’s capacity to improve quality outcomes and innovate within the healthcare delivery model.
Bears say
Huron Consulting Group Inc. has witnessed stagnant year-over-year revenue growth, particularly within its Healthcare segment, primarily due to declines in the strategy & innovation and distressed financial advisory practices. The first quarter typically sees reduced adjusted EBITDA and margins, influenced by increased operational costs including wage resets and stock-based compensation, which limit profitability. Additionally, ongoing financial pressures and market disruptions within the core healthcare and higher education industries may hinder future demand for Huron's services, exacerbating concerns regarding the firm’s revenue generation capabilities.
This aggregate rating is based on analysts' research of Huron Consulting Group and is not a guaranteed prediction by Public.com or investment advice.
HURN Analyst Forecast & Price Prediction
Start investing in HURN
Order type
Buy in
Order amount
Est. shares
0 shares